Photo by dmey503 from unsplash
191 get high-quality studies, independent from the expanding cannabis industry. To facilitate research, regulatory barriers for the conduct of experimental studies will need to be removed. In conclusion, there is… Click to show full abstract
191 get high-quality studies, independent from the expanding cannabis industry. To facilitate research, regulatory barriers for the conduct of experimental studies will need to be removed. In conclusion, there is emerging evidence about cannabis-related risks, but knowledge about the efects of legalizing recreational cannabis use is still at an embryonic stage. Scientists, stakeholders and policy makers will need to join forces to address this gap. Eva Hoch, Valentina Lorenzetti Cannabinoid Research and Treatment Group, Department of Psychiatry and Psychotherapy, Klinikum der Universität München, Munich, Germany; Department of Psychology, Ludwig Maximilian University München, Munich, Germany; School of Behavioural & Health Sciences, Australia Catholic University, Fitzroy, VIC, Australia
Journal Title: World Psychiatry
Year Published: 2020
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!